Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014

Feb 2014 GlobalData Lymphoma97 Pages Price :
$ 2500

GlobalData\'s clinical trial report, Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014\" provides data on the Anaplastic Large Cell Lymphoma (ALCL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Large Cell Lymphoma (ALCL) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Large Cell Lymphoma (ALCL) . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData\'s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 5
Introduction 6
Anaplastic Large Cell Lymphoma (ALCL) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Anaplastic Large Cell Lymphoma (ALCL) 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Anaplastic Large Cell Lymphoma (ALCL) 34
Jun 01, 2013: Takeda Highlights Data From Phase I/II Clinical Trial Examining Use Of Adcetris in Pediatric Patients With Hodgkin Lymphoma Or Systemic Anaplastic Large Cell Lymphoma 34
Jan 24, 2013: Seattle Genetics And Millennium Initiate Global Phase III Clinical Trial Of Adcetris In Front-line CD30-Expressing Mature T-Cell Lymphoma 34
May 23, 2012: Phase II Trial Results Of Brentuximab Vedotin Published In Journal Of Clinical Oncology 36
May 16, 2012: Children\'s Oncology Group Phase I Trial Of Crizotinib Achieves Positive Response 37
May 16, 2012: Crizotinib Shows Benefit In Children With Previously Treated Cancers In NIH-Supported Trial 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Seattle Genetics, Inc. 39
Clinical Trial Overview of Seattle Genetics, Inc. 39
Takeda Pharmaceutical Company Limited 41
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41
Bristol-Myers Squibb Company 43
Clinical Trial Overview of Bristol-Myers Squibb Company 43
Spectrum Pharmaceuticals, Inc. 44
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 44
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Xencor, Inc. 46
Clinical Trial Overview of Xencor, Inc. 46
Eisai Inc. 47
Clinical Trial Overview of Eisai Inc. 47
Bayer AG 48
Clinical Trial Overview of Bayer AG 48
Ariad Pharmaceuticals, Inc. 49
Clinical Trial Overview of Ariad Pharmaceuticals, Inc. 49
Akron Molecules GmbH 50
Clinical Trial Overview of Akron Molecules GmbH 50
Clinical Trial Overview of Top Institutes / Government 51
National Cancer Institute 51
Clinical Trial Overview of National Cancer Institute 51
Fred Hutchinson Cancer Research Center 54
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 54
University of Washington 57
Clinical Trial Overview of University of Washington 57
Children\'s Oncology Group 58
Clinical Trial Overview of Children\'s Oncology Group 58
The University of Texas M. D. Anderson Cancer Center 59
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 59
Case Comprehensive Cancer Center 60
Clinical Trial Overview of Case Comprehensive Cancer Center 60
Mayo Clinic 61
Clinical Trial Overview of Mayo Clinic 61
University of Nebraska 62
Clinical Trial Overview of University of Nebraska 62
City of Hope National Medical Center 63
Clinical Trial Overview of City of Hope National Medical Center 63
Roswell Park Cancer Institute 64
Clinical Trial Overview of Roswell Park Cancer Institute 64
Five Key Clinical Profiles 65

Appendix 94
Abbreviations 94
Definitions 94
Research Methodology 95
Secondary Research 95
About GlobalData 96
Contact Us 96
Disclaimer 96
Source 97

List of Table


Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2014* 39
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 41
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 43
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014* 44
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 45
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Xencor, Inc., 2014* 46
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2014* 47
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 48
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ariad Pharmaceuticals, Inc., 2014* 49
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Akron Molecules GmbH, 2014* 50
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 51
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 54
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 57
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children\'s Oncology Group, 2014* 58
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 59
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 60
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 61
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014* 62
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 63
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014* 64

List of Chart


Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 95

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 2500
$ 5000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top